Clinical Trial Update: Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the safety and efficacy of tenapanor for irritable bowel syndrome with constipation in pediatric patients aged 12 to less…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Tenapanor (tenapanor)

Snippet

Sponsor: Ardelyx | Conditions: Irritable Bowel Syndrome With Constipation (IBS-C) | Phase 3 | Status: RECRUITING